A registered study indexed because it matched monitored longevity research terms. Registry status: Recruiting. Registration does not establish safety or effectiveness.
What the source actually supports
- Evidence stage
- Phase not reported
- Study design
- RANDOMIZED · CROSSOVER · TREATMENT · QUADRUPLE
- Evidence population
- Human clinical study registration
- Participants
- 60
- Population
- ALL · 18 Years to 85 Years
- Duration
- 2025-11-26 to 2027-12-26
- Intervention
- Oral SPM-enriched marine oil (LIPINOVA); Placebo
- Comparator
- Control arm :Placebo (olive oil)
- Outcomes measured
- Flow-mediated dilation (FMD) — FMD will be measured at Week 0 (baseline), Week 12 (after a first administration period…; Shear rate area under the curve (SR-AUC) — These parameters will be measured at Week 0 (baseline), Week 12 (after a fir…; Difference after 12 -week- intervention with oral SPM supplementation or placebo in arterial stiffness — These paramete…; Change from initiation to the end of the 12 -week- intervention in endothelial injury — These parameters will be measur…; Change from initiation to the end of the 12 -week- intervention immune cell profile — These parameters will be measured…; Insulin sensitivity — These parameters will be measured at Week 0, Week12, Week16, Week28; Change in Body Fat Mass — These parameters will be measured at Week 0, Week12, Week16, Week28; Change in Lipid profile — These parameters will be measured at Week 0, Week12, Week16, Week28; Safety assessement by Liver function markers — These parameters will be measured at Week 0, Week12, Week16, Week28; Safety assessement by Renal function markers — These parameters will be measured at Week 0, Week12, Week16, Week28; Safety assessement by Coagulation markers — These parameters will be measured at Week 0, Week12, Week16, Week28; SPM levels — These parameters will be measured at Week 0, Week12, Week16, Week28; Questionnaires about perceptions and expectations about oral supplements for cardiovascular disease prevention — Week 0…; Health Literacy Questionnaire — Week 28; Questionnaire about vascular ageing awareness — Week 28
- Reported result
- No reusable finding-level result is available in this record.
Main limitationThis is a study registration. No reusable structured result is available here, so it cannot show whether the intervention worked or was safe.
Safety and approvalEligibility, adverse-event details, and clinical decisions must be checked in the official registry and with qualified clinicians. Trial registration is not regulatory approval and does not establish that an intervention is available.
Source supportStructured registry protocol metadata; no finding-level conclusion is generated.
Registration and recruitment status do not establish safety, efficacy, or regulatory approval.
Why this record appears here · 80% topic match
The title, summary, or source keywords matched one or more topics followed by immortal.life. A higher percentage means a stronger topic match; it does not rate safety, effectiveness, or study quality.
- Cardiovascular ageing · 80%Title contains controlled term: vascular ageing. Title supplies longevity context: ageing. Study type is explicitly identified as INTERVENTIONAL.
Automated source check 100% · update recency 100%. These figures help sort records; they are not medical ratings.